Crofoot MD Clinic and Research Center
Principal investigator in the PURPOSE trials
Long-Acting Injectable Lenacapavir Works in Both Prevention, Treatment of HIV: Gordon Crofoot, MD, PA
Lenacapavir works to both treat and prevent HIV, making it a promising drug should it be approved by the FDA later this month.